Characterization of a Broadly Neutralizing Monoclonal Antibody against SARS-CoV-2 Variants

Characterization of a Broadly Neutralizing Monoclonal Antibody against SARS-CoV-2 Variants

The constant mutation of SARS-CoV-2 has led to the emergence of new variants, which call for urgent effective therapeutic interventions. The trimeric spike (S) protein of SARS-CoV-2 is highly immunogenic with the receptor-binding domain (RBD) that binds first to the cellular receptor angiotensin-con...

Full description

Bibliographic Details
Main Authors: Tasnim Saifudin Zakir, Tao Meng, Lee Ching Pei Carmen, Justin Jang Hann Chu, Raymond Tzer Pin Lin, Mookkan Prabakaran
Format: Article
Language:English
Published: MDPI AG 2022-01-01
Series:Viruses
Subjects:
SARS-CoV-2 variants
spike RBD
neutralizing epitope
escape mutant
cross-neutralizing antibody
Online Access:https://www.mdpi.com/1999-4915/14/2/230

Internet

https://www.mdpi.com/1999-4915/14/2/230

Similar Items